Tokyo: Life Sciences and Health Care Horizons 2019
30 October 2019 | 1:30 PM - 6:00 PM (TST)
Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.
Tokyo: Life Sciences and Health Care Horizons 2019
30 October 2019 | 1:30 PM - 6:00 PM (TST)
Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.
Cross-border M&A: focus on antitrust filings
12 September 2019
Cross-border M&A: focus on antitrust filings
12 September 2019
New Era of Offshore Wind Power Projects in Europe, Japan, and the U.S.
25 April 2019
Japan is the latest country to pass a new law, “the Act regarding the Promotion of Use of Sea Areas to Develop Offshore Renewable Energy Facilities" (Saiene Kaiiki Riyou Hou), to ...
Exciting Trends in Japanese Tech M&A
14 March 2019
In 2018 business headlines were dominated by Japanese M&A deals at levels unprecedented since the 1980s. This trend is expected to continue in tech M&A with Japanese investors...
Exciting Trends in Japanese Tech M&A
14 March 2019
In 2018 business headlines were dominated by Japanese M&A deals at levels unprecedented since the 1980s. This trend is expected to continue in tech M&A with Japanese investors...
Going Global 2018
Tokyo: 28 Nov 2018, Osaka: 26 Nov 2018
Cross-practice, multi-track seminar on advanced trademark issues, global M&A transactions, global patent updates for technology companies, energy investments, and recent...
